Objetivo: Abordar as diferentes facetas do cuidado de pacientes com neoplasias cutâneas a partir dos pilares que sustentam o cuidado centralizado no paciente, incluindo multidisciplinariedade, cooperação entre equipes e especialização.

Público-alvo: Dermatologistas, oncologistas clínicos, radio oncologistas e cirurgiões oncológicos, além de acadêmicos e profissionais de saúde interessados no diagnóstico e tratamento dos tumores cutâneos.

III Simpósio Internacional de Oncologia Cutânea

Local:
Sírio-Libanês de Ensino e Pesquisa
Rua Professor Daher Cutait, 69 – Bela Vista - São Paulo – SP – Brasil

Dates:
Scientific symposium – April, 2nd and 3rd 2020

International Guests:
- Alexander Eggermont (Surgical Oncology)
- Sanjiv Agarwala (Clinical Oncology)
- Joseph Malvehy (Dermatology)

Scientific Committee:

  • Grupo de Tumores Cutâneos e Sarcomas do Hospital Sírio-Libanês (Group of Cutaneous Malignancies and Sarcoma – Hospital Sírio-Libanês)
  • Centro de Oncologia do Hospital Sírio-Libanês (Oncology Center – Hospital Sírio-Libanês)
  • Residência Médica em Dermatologia – Hospital Sírio-Libanês
  • Residência Médica em Oncologia Clínica – Hospital Sírio-Libanês

Inscreva-se


Alexander Eggermont

Professor Alexander Eggermont is appointed CSO of the Princess Máxima Center for pediatric oncology from October 1, 2019. He will be succeeding professor Hans Clevers, who stepped down on June 1. For the past nine years Eggermont has been General Director of Gustave Roussy Cancer Campus Grand Paris, the famous oncological healthcare and research institute in France. Here, he developed Europe’s largest Phase 1-2 drug development and immunotherapy development program amongst others.

Josep Malvehy

As a Chairman of the Melanoma Unit at the Hospital Clinic of Barcelona, and dermatologist devoted to research and clinical management of patients with melanocytic lesions, Dr. Malvehy emphasizes the importance of projects promoting research, teaching and advice to families affected with congenital nevi. He is convinced that working with many other professionals and patient associations will help improve the quality of life of patients.
Hospital Clinic de Barcelona, Barcelona, Spain
Dermatology, oncology

Sanjiv Agarwala

Sanjiv Agarwala, MD, is Professor of Oncology at Temple University School of Medicine, in Philadelphia. He is nationally and internationally recognized as an expert in the research and treatment of melanoma and immunotherapy of cancer and has presented and led numerous conferences and meetings across the globe. He has written and contributed to over 200 publications and book chapters on melanoma, immune-oncology and other research areas and has been principal investigator for multiple clinical trials involving immunotherapy and targeted therapy for melanoma, head & neck and renal cancer and other malignancies. He has received several honors, including listings as one of America’s top doctors for cancer and best doctors in the United States.

Palestrantes

Romualdo Barroso, MD, PhD

Daniele Assad, MD, MSc, PhD

Renata Sandoval, MD, MSc

Natália Polidorio, MD, MSc

José Bines, MD, PhD

Marcelo Cruz, MD, MSc

Gabriela Siqueira, MD

Tatiana Strava, MD

Mauro Passos, MD

Daniel Marques, MD

Felipe Andrade, MD


Program Overview

Programação: 02 de abril de 2020 (Quinta-feira)
Schedule: April 2, 2020 (Thursday)

Program – Day 1

13:30-13:38

Opening

Francisco Belfort

Module – Hot topics in melanoma – a multidisciplinary approach

Chairs: José Antonio Sanches and Claudia Regina de Oliveira

13:40-13:58

A closer look into current scenario and trends in melanoma epidemiology - why are the numbers increasing?

Jade Martins

14:00-14:18

The impact of awareness campaigns – are they effective?

Flávio

Cavarsan

14:20-14:38

The role of circulating DNA in the management of melanoma

Mariana Petaccia

14:40-14:58

Cutting-edge imaging techniques in melanoma

Luciana

Zattar

15:00-15:18

Current applications of tele-dermatoscopy and how this approach will shape de future

Josep

Malvehy

15:20-15:40

Discussion / Q&A

15:40-16:10

Interval / Coffee Break

Plenary session – Day 1

Chairs: Luiza Dib and Fábio Ferreira

16:10-16:40

Plenary 1 – Perioperative systemic treatment in melanoma – updates and perspectives

Alexander Eggermont

16:40-17:10

Plenary 2  – The current role of microscopically controlled surgery in cutaneous malignancies

Josep

Malvehy

17:10-17:30

Roundtable and Q&A

17:30-17:40

Closure – Day 1

 

Programação: 03 de abril de 2020 (Sexta-feira)
Schedule: April 3, 2020 (Friday)

Program – Day 2

Module: Challenges in the management of melanoma

Chairs: Alberto Wainstein and Luis Fernando Tovo

08:30-08:48

Hereditary syndromes in melanoma and indications for investigation of germline mutations

 

Maria Isabel Achatz

08:50-09:08

Surgical approaches to anatomically unfavorable melanomas

Eduardo

 Bertolli

09:10-09:28

Skin cancer in the elderly – not the same patients

Theodora Karnakis

09:30-10:00

Roundtable: multidisciplinary approach to patients receiving BRAF/MEK inhibitors and ICP – what to expect and how to manage AEs?

Reumato

Roberto Kalil

Daniel Ciampi

Rodrigo Munhoz

Reinaldo Tovo

Allan Pereira

10:00-10:30

Interval / Coffee Break

Module: Case-based roundtables

Chairs: Rodrigo Munhoz and Marina Sahade

 

 

 

 

10:30-11:00

 

Case 1: Adjuvant melanoma – I recommend ICP

Andreia

Melo

Case 1: Adjuvant melanoma – I recommend TT

Milton

 Barros

 

 

Case 1: Discussion

Alexander Eggermont, Andreia Melo, Milton Barros, Luiz Flávio Coutinho

11:00-11:30

 

Case 2: Management of patients with oligometastatic disease

Fabio Ferreira

Case 2: Discussion

Fabio Ferreira, Sanjiv Agarwala, Samir Abdallah Hanna, Francisco Belfort, Abner Barrozo, Rodrigo Villarroel

11:30-12:00

 

Case 3: Management of SCC and BCC – optimal initial approach

Reinaldo Tovo

Case 3: Discussion

Vera de Barros / Ana Maria Sortino / Antonio Sérgio Zafred Marcelino / Flávio Cavarsan / Fábio Ferreira / Francisco Belfort / Josep Malvehy

12:00-12:40

Satellite symposium 1

 

12:40-13:20

Satellite symposium 2

 

Plenary session – Day 2

Chairs:  Cristina Abdalla and Francisco Belfort

13:30-14:00

Plenary 3 -   Which melanoma patients should still undergo surgery? From localized do advanced disease

Alexander Eggermont

14:00-14:30

Plenary 4 -   Beyond current standards – what to expect for patients with advanced melanoma?

Sanjiv Agarwala

14:30-14:50

Roundtable and Q&A

 

14:50-15:20

Interval / Coffee Break

Module: Non-melanoma skin cancers

Chairs: Frederico Teixeira Jr and Melissa Fugimori

15:20-15:38

Overview: advances in the systemic treatment of cSCC and BCC

Rodrigo Guedes

15:40-15:58

Roundtable: management of locally advanced squamous cell carcinomas and basal cell carcinomas

Marina Sahade / Felice Riccardi / Sergio Couto/ João Luis Fernandes / Luis Fernando Tovo / Tatiana Strava

16:00-16:18

Merkel cell carcinoma – treatment updates and opportunities for perioperative approaches

Rafael

Schmerling

16:20-16:30

Discussion / Q&A

Module: Areas of uncertainty

 Chairs: André Molina and Eduardo Akaishi

16:30-16:48

What is the optimal surgical approach to patients with clinically involved LN?

Alexander Eggermont

16:50-17:08

Challenges in particular melanocytic lesions: form melanosis to Spitzoid tumours.

Josep

Malvehy

17:10-17:28

Melanoma and pregnancy – risks and management

Miguel

Brandão

17:30-17:48

Combining IO and RT – where are we?

Samir

Abdallah Hanna

17:50-18:00

Discussion / Q&A

18:00

Closure


Inscreva-se em Nossos Cursos

Inscrição em Cursos

Para informações, entre em contato

Localização

Rua Prof. Daher Cutait, 69
Bela Vista – São Paulo (SP)
CEP: 01308-060

Dúvidas e informações sobre os cursos

0800 730 2211